Analysts are confident in iRhythm Technologies' path to profitability, expecting a high year-on-year growth rate. The company's low debt obligation reduces the risk around investing in the loss-making company.

Daniel Wilson's recent sale, even below the current price of US$113, could be seen as a discouraging sign. The lack of insider purchases over the last year and the recent sale might require careful consideration before buying shares.

The author believes iRhythm Technologies is undervalued and sees a potential future buying opportunity due to its high beta, strong foresee earnings growth and positive outlook not fully reflected in current share price.

The fact that insiders have offloaded significant shares without making any recent purchases, and despite owning a decent, but not substantial portion of the company signals caution for potential buyers of the iRhythm Technologies stock.

Latest List of Companies With Silicon Valley Bank, $SIVB, Deposits:
1. Circle: $3.3 billion
2. Bill․com: $670 million
3. Roku: $487 million
4. BlockFi: $227 million
5. Roblox: $150 million
6. Sunrun: $80 million
7. Ginkgo Bio: $74 million
8. iRhythm: $55 million
9. Rocket Lab: $38 million
10. Sangamo Thera: $34 million
11. Lending Club: $21 million
12. Huuuge Inc: $24 million
13. Payoneer: $20 million
14. Ambarella: $17 million
15. Protagonist Thera: $13 million
16. Oncorus: $10 million
17. Eig...